Loading...
Loading...
Analysts at Goldman Sachs upgraded
Clovis Oncology, Inc. CLVS from Neutral to Buy. The price target for Clovis Oncology has been raised from $60 to $66. Clovis Oncology shares closed at $77.40 on Friday.
Deutsche Bank upgraded
Diana Shipping Inc. DSX from Hold to Buy. Diana Shipping shares closed at $6.09 on Friday.
Analysts at Credit Suisse upgraded
St Jude Medical Inc.STJ from Underperform to Neutral. The price target for St Jude Medical is set to $74. St Jude Medical shares closed at $68.17 on Friday.
Analysts at UBS upgraded
Netflix, Inc. NFLX from Neutral to Buy. The price target for Netflix has been raised from $370 to $565. Netflix shares closed at $454.57 on Friday.
BMO Capital upgraded
AbbVie Inc. ABBV from Market Perform to Outperform. The price target for AbbVie has been raised from $60 to $68. AbbVie shares closed at $61.49 on Friday.
Analysts at Jefferies upgraded
UnitedHealth Group Incorporated from Hold to Buy. UnitedHealth shares closed at $119.00 on Friday.
Citigroup upgraded
Freeport-McMoRan Inc. FCXLoading...
Loading...
from Neutral to Buy. The price target for Freeport-McMoRan has been raised from $19 to $23. Freeport-McMoRan shares closed at $18.25 on Friday.
Analysts at Piper Jaffray upgraded
Christopher & Banks CorporationCBK from Neutral to Overweight. The price target for Christopher & Banks has been raised from $5 to $10. Christopher & Banks shares closed at $5.63 on Friday.
Bank of America upgraded
Marathon Oil CorporationMRO from Neutral to Buy. The price target for Marathon Oil has been raised to $36. Marathon Oil shares closed at $29.18 on Friday.
Analysts at KeyBanc upgraded
IPC Healthcare, Inc. IPCM from Sector Weight to Overweight. The price target for IPC Healthcare is set to $56. IPC Healthcare shares closed at $48.65 on Friday.
Baird upgraded
The Habit Restaurants, Inc. HABT from Neutral to Outperform. The price target for The Habit Restaurants is set to $41. The Habit Restaurants shares closed at $31.00 on Friday.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in